Treatment of metastatic pancreatic adenocarcinoma: new options and promising strategies
Lowery, M.A.; O'Reilly, E.M.
Oncology 28(1): 76; 78
2014
ISSN/ISBN: 0890-9091 PMID: 24683722 Document Number: 675331
Document emailed within 1 workday
Related Documents
Feleppa, A.E.; Ellison, N.M. 1981: Metastatic pancreatic adenocarcinoma of the tonsil Ear Nose and Throat Journal 60(3): 136-138Lee, J.J.; Sun, W. 2016: Options for Second-Line Treatment in Metastatic Colorectal Cancer Clinical Advances in Hematology and Oncology: H&o 14(1): 46-54
Sabourin, G. 2012: Victrelis and Incivek against hepatitis C: some promising options Perspective Infirmiere: Revue Officielle de l'Ordre des Infirmieres et Infirmiers du Quebec 9(1): 58-59
Willett, C.G.; Clark, J.W. 2003: Update on combined-modality treatment options for pancreatic cancer Oncology 17(12 Suppl. 13): 29-36
Bilici, A.; Arslan, C.; Altundag, K. 2012: Promising therapeutic options in triple-negative breast cancer Journal of BUON: Official Journal of the Balkan Union of Oncology 17(2): 209-222
Barbier, L.; Delpero, J.-R. 2014: Pancreatic adenocarcinoma: what treatment? La Revue du Praticien 64(9): 1297-1298
Ettinghausen, S.E.; Schwartzentruber, D.J.; Sindelar, W.F. 1995: Evolving strategies for the treatment of adenocarcinoma of the pancreas. a review Journal of Clinical Gastroenterology 21(1): 48-60
Senderowicz, A.M.; Johnson, J.R.; Sridhara, R.; Zimmerman, P.; Justice, R.; Pazdur, R. 2007: Erlotinib/gemcitabine for first-line treatment of locally advanced or metastatic adenocarcinoma of the pancreas Oncology 21(14): 1696-1706; Discussion: 1706-1709 1712, 1715
Denefrio, J.M.; Kaplan, R.S.; Eisenberger, M.A.; Lessner, H.E. 1981: Phase Ii study of cyclophosphamide and cytarabine in the treatment of metastatic adenocarcinoma of the colon and rectum Cancer Treatment Reports 65(1-2): 163-164
Pisters, P.W.T.; Wolff, R.A.; Crane, C.H.; Evans, D.B. 2005: Combined-modality treatment for operable pancreatic adenocarcinoma Oncology 19(3): 393-404; 409; Discussion: 409-410; 412-416
Milosević, P.; Dolaji, M.; Milosević, D.; Ikonić, N.; Popović, A.; Veljković, R. 2011: Role of surgical resection in treatment of pancreatic adenocarcinoma Medicinski Pregled 64(9-10): 448-452
Sperti, C.; Merigliano, S.; Moletta, L. 2015: Metastatic pancreatic tumors: what is the optimal treatment? Minerva Chirurgica 70(2): 131-139
Polyzos, A.; Koulentianos, E.; Tzianoumis, L.; Sfikakis, P. 1989: Increased dosage of epirubicin and mitomycin-C for the treatment of metastatic adenocarcinoma of unknown primary site Journal of ChemoTherapy 1(4 Suppl): 1185-1186
Tada, M.; Omata, M.; Kawai, S.; Saisho, H.; Ohto, M.; Saiki, R.K.; Sninsky, J.J. 1993: Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma Cancer Research 53(11): 2472-2474
Shiba, H.; Misawa, T.; Fujiwara, Y.; Futagawa, Y.; Furukawa, K.; Haruki, K.; Iida, T.; Iwase, R.; Yanaga, K. 2013: Negative impact of fresh-frozen plasma transfusion on prognosis of pancreatic ductal adenocarcinoma after pancreatic resection Anticancer Research 33(9): 4041-4047
Tepel, J.; March, C.; Ketterer, T.; Kapischke, M.; Arlt, A.; Kremer, B.; Kalthoff, H.; Kruse, M-Luise. 2006: A modified random oligonucleotide-based combination therapy for adjuvant treatment of pancreatic ductal adenocarcinoma International Journal of Oncology 28(5): 1105-1112
Su, X.; Yao, J.; Jiang, Y.; Li, J.; Han, J.; Sun, W. 2014: Promising antibody testing strategies for early infant HIV infection diagnosis in China Plos one 9(6): E99935
Tsukamoto, T.; Takahama, M.; Kodai, S.; Kanazawa, A.; Hori, T.; Kaizaki, R.; Takatsuka, S.; Komatsu, R. 2017: Long-Term Survival after Multidisciplinary Treatment for Resected Pancreatic Adenocarcinoma with Recurrence of Pulmonary Metastases - A Case Report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 44(12): 1883-1885
Nicolson, G.L.; Lembo, T.M.; Welch, D.R. 1988: Growth of rat mammary adenocarcinoma cells in semisolid clonogenic medium not correlated with spontaneous metastatic behavior: heterogeneity in the metastatic, antigenic, enzymatic, and drug sensitivity properties of cells from different sized colonies Cancer Research 48(2): 399-404
Lygidakis, N.J.; Dedemati, G.; Spenzaris, N.; Theodoropoulou, M. 1997: Unresectable pancreatic cancer: is a multi-modality approach a promising therapeutical alternative? Hepato-Gastroenterology 44(16): 1222-1228